Search HDBuzz
Through the eyes of a friend: changes in mood and behavior in early HD
Companions of HD gene carriers are more likely to notice psychological changes in presymptomatic HD.
December 02, 2015
A recycled drug gives us new insight in to HD
An existing drug could give a boost to HD brain cells – but it may need more testing before it’s back in the clinic
December 15, 2015
Looking Past the Spin: Results from a Clinical Trial of Cysteamine
Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.
December 18, 2015
Huntington's Disease Therapeutics Conference 2016 - day 3
Stem cells and modeling Huntington's disease in our final Therapeutics Conference report
February 28, 2016
Thinking clearly about the earliest symptoms of HD and which brain regions control them
HD reaches more brain structures than we thought: new research broadens our understanding of the earliest signs of HD
April 18, 2016
Electron beam snaps best images yet of Huntington's disease protein
Electrons enable huntingtin protein, the cause of Huntington's disease, to be visualised at highest resolution ever
June 21, 2016
Slightly long CAG repeats are more common than we thought
A new population study reveals that relatively mild forms of the HD mutation are much more common than we thought
July 05, 2016
A support system gone wrong - glial cells contribute to HD symptoms
An elegant new study helps determine how much brain cells called glia matter to HD symptoms
August 02, 2016
Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
September 30, 2016
Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD
December 16, 2016
You can also read About HDBuzz for information on HDBuzz or try your search on a search engine.